Brekken; Rolf A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brekken; Rolf A..The latest application filed is for "small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof".

Company Profile

1.18.10

Brekken; Rolf A. - Dallas TX
Brekken; Rolf A. - Seattle WA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cancer specific lipid targeted peptidomimetics Grant 10,849,875 - Udugamasooriya , et al. December 1, 2	2020-12-01
Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof Grant 10,370,360 - Brekken , et al.	2019-08-06
Screen and use of therapeutics for pancreatic ductal adenocarcinoma Grant 9,986,723 - Wilkie , et al. June 5, 2	2018-06-05
Small-molecule Inhibitors Targeting Discoidin Domain Receptor 1 And Uses Thereof App 20180022730 - BREKKEN; Rolf A. ; et al.	2018-01-25
Cancer Treatment Comprising Therapeutics That Bind to Phosphatidylserine App 20160199509 - Thorpe; Philip E. ; et al.	2016-07-14
Screen And Use Of Therapeutics For Pancreatic Ductal Adenocarcinoma App 20160128311 - WILKIE; Thomas M. ; et al.	2016-05-12
Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine App 20140205544 - Thorpe; Philip E. ; et al.	2014-07-24
Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids Grant 8,709,430 - Thorpe , et al. April 29, 2	2014-04-29
Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids Grant 7,790,860 - Thorpe , et al. September 7, 2	2010-09-07
Targeting and Imaging Tumor Vasculature Using Conjugates That Bind to Aminophospholipids App 20090191121 - Thorpe; Philip E. ; et al.	2009-07-30
Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids Grant 7,550,141 - Thorpe , et al. June 23, 2	2009-06-23
Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids Grant 7,067,109 - Thorpe , et al. June 27, 2	2006-06-27
Antibody methods for selectively inhibiting VEGF Grant 7,056,509 - Thorpe , et al. June 6, 2	2006-06-06
Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids App 20060083745 - Thorpe; Philip E. ; et al.	2006-04-20
Antibody conjugate methods for selectively inhibiting VEGF App 20050123537 - Thorpe, Philip E. ; et al.	2005-06-09
Antibody kits for selectively inhibiting VEGF Grant 6,887,468 - Thorpe , et al. May 3, 2	2005-05-03
Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids App 20050089523 - Thorpe, Philip E. ; et al.	2005-04-28
Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids Grant 6,818,213 - Thorpe , et al. November 16, 2	2004-11-16
Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids Grant 6,783,760 - Thorpe , et al. August 31, 2	2004-08-31
Antibody conjugate methods for selectively inhibiting VEGF Grant 6,703,020 - Thorpe , et al. March 9, 2	2004-03-09
Antibody conjugate formulations for selectively inhibiting VEGF Grant 6,676,941 - Thorpe , et al. January 13, 2	2004-01-13
Antibody methods for selectively inhibiting VEGF App 20030175276 - Thorpe, Philip E. ; et al.	2003-09-18
Antibody methods for selectively inhibiting VEGF Grant 6,524,583 - Thorpe , et al. February 25, 2	2003-02-25
Antibody conjugate formulations for selectively inhibiting VEGF App 20020119153 - Thorpe, Philip E. ; et al.	2002-08-29
Antibody conjugate kits for selectively inhibiting VEGF Grant 6,416,758 - Thorpe , et al. July 9, 2	2002-07-09
Antibody compositions for selectively inhibiting VEGF Grant 6,342,219 - Thorpe , et al. January 29, 2	2002-01-29
Antibody conjugate compositions for selectively inhibiting VEGF Grant 6,342,221 - Thorpe , et al. January 29, 2	2002-01-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.